Gerontology Department, Faculty of Medicine and Pharmacy, Vrije Universiteit Brussel, Brussels, Belgium.
Frailty in Ageing Research (FRIA) Group, Faculty of Medicine and Pharmacy, Vrije Universiteit Brussel, Laarbeeklaan 103, B-1090, Brussels, Belgium.
Aging Clin Exp Res. 2023 Apr;35(4):835-845. doi: 10.1007/s40520-023-02365-3. Epub 2023 Mar 10.
We developed Eforto®, an innovative system for (self-)monitoring of grip strength (GS) and muscle fatigability (Fatigue Resistance (FR = time until GS decreased to 50% of maximum during sustained contraction) and grip work (GW = area under the strength-time curve)). The Eforto® system consists of a rubber bulb that is wirelessly connected to a smartphone-based application, and a telemonitoring platform. The aim was to evaluate the validity and reliability of Eforto® to measure muscle fatigability.
Community-dwelling older persons (n = 61), geriatric inpatients (n = 26) and hip fracture patients (n = 25) were evaluated for GS and muscle fatigability. In community dwellers fatigability was tested twice in the clinic (once with Eforto®, once with Martin Vigorimeter (MV), standard analog handgrip system) and for six consecutive days as a self-assessment at home with Eforto®. In hospitalized participants, fatigability was tested twice using Eforto®, once by a researcher and once by a health professional.
Criterion validity was supported by good to excellent correlations between Eforto® and MV for GS (r = 0.95) and muscle fatigability (FR r = 0.81 and GW r = 0.73), and no significant differences in measurements between both systems. Inter-rater and intra-rater reliability for GW were moderate to excellent (intra-class correlation: 0.59-0.94). The standard error of measurement for GW was small for geriatric inpatients and hip fracture patients (224.5 and 386.5 kPas) and higher for community-dwellers (661.5 kPas).
DISCUSSION/CONCLUSION: We established the criterion validity and reliability of Eforto® in older community-dwelling persons and hospitalized patients, supporting the implementation of Eforto® for (self-)monitoring of muscle fatigability.
我们开发了 Eforto®,这是一种用于(自我)监测握力(GS)和肌肉疲劳性(疲劳抵抗力(FR= 最大握力持续收缩时下降到 50%所需的时间)和握力做功(GW= 力量-时间曲线下的面积))的创新系统。Eforto®系统由一个无线连接到基于智能手机的应用程序的橡胶球和一个远程监测平台组成。目的是评估 Eforto®测量肌肉疲劳性的有效性和可靠性。
社区居住的老年人(n=61)、老年住院患者(n=26)和髋部骨折患者(n=25)评估 GS 和肌肉疲劳性。在社区居民中,疲劳性在诊所中进行了两次测试(一次使用 Eforto®,一次使用 Martin Vigorimeter (MV),标准模拟手握系统),并在家中使用 Eforto®连续六天进行自我评估。在住院患者中,疲劳性使用 Eforto®进行了两次测试,一次由研究人员进行,一次由健康专业人员进行。
Eforto®与 MV 之间的良好到极好的相关性支持了 Eforto®的标准有效性,用于 GS(r=0.95)和肌肉疲劳性(FR r=0.81 和 GW r=0.73),两种系统之间的测量值无显著差异。GW 的组内和组间可靠性为中等到极好(组内相关系数:0.59-0.94)。GW 的测量标准误差对于老年住院患者和髋部骨折患者较小(224.5 和 386.5 kPas),对于社区居民较高(661.5 kPas)。
讨论/结论:我们确定了 Eforto®在老年社区居民和住院患者中的标准有效性和可靠性,支持 Eforto®用于(自我)监测肌肉疲劳性。